JP2021129702A - Cell transplantation device - Google Patents

Cell transplantation device Download PDF

Info

Publication number
JP2021129702A
JP2021129702A JP2020026242A JP2020026242A JP2021129702A JP 2021129702 A JP2021129702 A JP 2021129702A JP 2020026242 A JP2020026242 A JP 2020026242A JP 2020026242 A JP2020026242 A JP 2020026242A JP 2021129702 A JP2021129702 A JP 2021129702A
Authority
JP
Japan
Prior art keywords
inner cylinder
cell group
cylinder portion
needle
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020026242A
Other languages
Japanese (ja)
Other versions
JP7484211B2 (en
Inventor
佳菜 吉原
Kana YOSHIHARA
佳菜 吉原
賢洋 兒玉
Masahiro Kodama
賢洋 兒玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toppan Inc
Original Assignee
Toppan Printing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toppan Printing Co Ltd filed Critical Toppan Printing Co Ltd
Priority to JP2020026242A priority Critical patent/JP7484211B2/en
Publication of JP2021129702A publication Critical patent/JP2021129702A/en
Application granted granted Critical
Publication of JP7484211B2 publication Critical patent/JP7484211B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

To provide a cell transplantation device capable of delivering a cell group and substances other than the cell group into an organism.SOLUTION: A cell transplantation device 100 is configured to dispose a cell group in an object area in an organism. The cell transplantation device 100 comprises: a tubular needle-like part 20 extending along one direction; and a plurality of inner tube parts 30 positioned inside the needle-like part 20. The inner tube parts 30 include a first inner tube part for transporting the cell group and a second inner tube part for transporting substances other than the cell group.SELECTED DRAWING: Figure 1

Description

本発明は、細胞の移植に用いられる細胞移植装置に関する。 The present invention relates to a cell transplant device used for cell transplantation.

細胞群を生体内へ移植する技術が開発されている。例えば、毛を作り出す器官である毛包の形成に寄与する細胞群を培養し、この細胞群を皮内へ移植することによって、毛髪を再生させることが試みられている。毛髪の良好な再生のためには、移植された細胞群から、正常な組織構造を有して良好な毛髪の形成能力を有する毛包が形成されることが望ましい。そこで、こうした毛包を形成可能な細胞群の製造方法について、様々な研究開発が行われている(例えば、特許文献1〜3参照)。さらに、培養された細胞群を、培養容器から生体内へ移すためのデバイスである細胞移植装置の開発も進められている(例えば、特許文献4参照)。細胞移植装置は、針状に尖る筒状部を備え、筒状部の内部へ培養容器から細胞群を取り込む。筒状部が皮膚等の移植の対象箇所を刺した後、筒状部の先端から細胞群が放出されることにより、細胞群が生体内に配置される。 A technique for transplanting a group of cells into a living body has been developed. For example, attempts have been made to regenerate hair by culturing a group of cells that contribute to the formation of hair follicles, which are organs that produce hair, and transplanting this group of cells into the skin. For good hair regeneration, it is desirable that hair follicles having a normal tissue structure and good hair forming ability are formed from the transplanted cell group. Therefore, various studies and developments have been carried out on a method for producing a cell group capable of forming such hair follicles (see, for example, Patent Documents 1 to 3). Further, development of a cell transplantation device, which is a device for transferring a cultured cell group from a culture vessel into a living body, is also underway (see, for example, Patent Document 4). The cell transplantation device is provided with a needle-shaped pointed tubular portion, and the cell group is taken into the inside of the tubular portion from the culture vessel. After the tubular portion pierces the target portion of transplantation such as skin, the cell group is released from the tip of the tubular portion, so that the cell group is arranged in the living body.

国際公開第2017/073625号International Publication No. 2017/073625 国際公開第2012/108069号International Publication No. 2012/108069 特開2008−29331号公報Japanese Unexamined Patent Publication No. 2008-29331 国際公開第2019/064653号International Publication No. 2019/064653

ところで、細胞群の移植に際して、細胞群と共に細胞群以外の物質を生体内に供給したいという要請がある。例えば、移植された細胞群におけるその機能の良好な発現のためには、細胞群と共に、細胞群の機能の発現を補助する補助物質を生体内に供給することが好ましい。補助物質は、例えば、細胞のための栄養成分や、生体内への細胞群の定着を補助する物質である。上記細胞移植装置は、培養容器内にて細胞群を保護している液体である保護液を細胞群と共に筒状部内へ取り込み、当該保護液を細胞群と共に生体内に放出することが可能ではあるものの、取り込まれる保護液の量や成分は、生体内において細胞群の活性を高めるために十分であるとは限らない。また、上記細胞移植装置においては、保護液とは異なる物質を筒状部内にさらに取り込むことは困難である。一方で、細胞移植装置とは別のデバイスを用いて細胞群とは別に補助物質を生体内に供給することは、細胞群の移植時と補助物質の供給時とでのデバイスの交換や、細胞群の移植位置と補助物質の供給位置との位置合わせを要するため、細胞群および補助物質を生体内に送り込むための作業が煩雑になってしまう。 By the way, when transplanting a cell group, there is a request to supply a substance other than the cell group to the living body together with the cell group. For example, in order to achieve good expression of the function in the transplanted cell group, it is preferable to supply an auxiliary substance that assists the expression of the function of the cell group in vivo together with the cell group. Auxiliary substances are, for example, nutritional components for cells and substances that assist the establishment of cell groups in a living body. The cell transplantation device can take a protective solution, which is a liquid that protects the cell group in the culture vessel, into the tubular part together with the cell group, and release the protective solution into the living body together with the cell group. However, the amount and components of the protective solution taken up are not always sufficient to enhance the activity of the cell group in the living body. Further, in the cell transplantation device, it is difficult to further take in a substance different from the protective solution into the tubular portion. On the other hand, supplying an auxiliary substance to the living body separately from the cell group using a device different from the cell transplantation device means exchanging the device between the time of transplanting the cell group and the time of supplying the auxiliary substance, and the cells. Since it is necessary to align the transplantation position of the group with the supply position of the auxiliary substance, the work for sending the cell group and the auxiliary substance into the living body becomes complicated.

本発明は、細胞群と細胞群以外の物質とを生体内に送達可能とした細胞移植装置を提供することを目的とする。 An object of the present invention is to provide a cell transplantation apparatus capable of delivering a cell group and a substance other than the cell group into a living body.

上記課題を解決する細胞移植装置は、生体内の対象領域に、細胞群を配置するための細胞移植装置であって、1つの方向に沿って延びる筒状の針状部と、前記針状部の内側に位置する複数の内筒部と、を備え、前記複数の内筒部には、前記細胞群を移送するための第1内筒部と、前記細胞群以外の物質を移送するための第2内筒部とが含まれる。 The cell transplantation device that solves the above problems is a cell transplantation device for arranging a cell group in a target region in a living body, and has a tubular needle-shaped portion extending along one direction and the needle-shaped portion. A plurality of inner cylinders located inside the cell group are provided, and a first inner cylinder portion for transferring the cell group and a substance other than the cell group are transferred to the plurality of inner cylinder portions. A second inner cylinder portion is included.

上記構成によれば、第1内筒部に細胞群を配し、第2内筒部に細胞群以外の物質である対象物質を配することにより、1つの針状部の内部に細胞群と対象物質とを取り込んで、これらを生体内に移送することができる。そして、1つの針状部から細胞群と対象物質とを放出することができるため、生体内において細胞群が配置された領域の付近に対象物質を供給することができる。したがって、細胞群と細胞群以外の物質とを生体内に容易に送達することができる。 According to the above configuration, by arranging the cell group in the first inner cylinder portion and arranging the target substance which is a substance other than the cell group in the second inner cylinder portion, the cell group is formed inside one needle-shaped portion. It is possible to take in the target substance and transfer them into the living body. Then, since the cell group and the target substance can be released from one needle-shaped portion, the target substance can be supplied to the vicinity of the region where the cell group is arranged in the living body. Therefore, the cell group and the substance other than the cell group can be easily delivered into the living body.

上記構成において、前記内筒部は、前記内筒部の先端部が前記針状部の内部に位置した第1状態と、前記内筒部の先端部が前記針状部の先端部の開口部から突き出した第2状態との間で、前記針状部に対して相対的に移動可能に構成されていてもよい。 In the above configuration, the inner cylinder portion has a first state in which the tip portion of the inner cylinder portion is located inside the needle-shaped portion, and the tip portion of the inner cylinder portion is an opening of the tip portion of the needle-shaped portion. It may be configured to be movable relative to the needle-shaped portion with respect to the second state protruding from.

上記構成によれば、第1状態で生体に針状部を刺すこと、および、第2状態で細胞群および対象物質の取り込みや放出を行うことができる。したがって、細胞群および対象物質の生体内への送達が円滑に進められる。 According to the above configuration, the needle-shaped portion can be pierced into the living body in the first state, and the cell group and the target substance can be taken in and released in the second state. Therefore, the delivery of the cell group and the target substance into the living body is smoothly promoted.

上記構成において、前記複数の内筒部は、前記内筒部ごとに、前記第1状態と前記第2状態との間で移動可能に構成されていてもよい。
上記構成によれば、複数の内筒部を1つずつ針状部の開口部から出し入れすることができるため、内筒部の周囲の空間に余裕のある状態で、細胞群および対象物質の取り込みや放出を行うことができる。したがって、これらの作業が円滑に進められる。
In the above configuration, the plurality of inner cylinder portions may be configured to be movable between the first state and the second state for each inner cylinder portion.
According to the above configuration, since a plurality of inner cylinders can be taken in and out one by one from the opening of the needle-shaped portion, the cell group and the target substance can be taken in with a sufficient space around the inner cylinder. And can be released. Therefore, these operations can proceed smoothly.

上記構成において、2以上の前記内筒部が、同時に、前記第1状態と前記第2状態との間で移動可能に構成されていてもよい。
上記構成によれば、複数の内筒部を1つずつ動かす場合と比較して、内筒部の動きの制御が簡易になる。
In the above configuration, the two or more inner cylinder portions may be configured to be movable between the first state and the second state at the same time.
According to the above configuration, control of the movement of the inner cylinder portion becomes simpler as compared with the case where a plurality of inner cylinder portions are moved one by one.

上記構成において、前記細胞群は、細胞の集合体であり、前記第1内筒部は、前記第1内筒部内を吸引する機構に接続され、前記吸引によって前記第1内筒部の先端部から前記第1内筒部内に前記細胞群を取り込んでもよい。 In the above configuration, the cell group is an aggregate of cells, the first inner cylinder portion is connected to a mechanism for sucking the inside of the first inner cylinder portion, and the tip portion of the first inner cylinder portion is connected by the suction. The cell group may be taken into the first inner cylinder portion.

上記構成によれば、細胞の集合体を的確に内筒部の内部に取り込むことが可能であり、所望の数だけ細胞群を内筒部内に取り込むことも容易である。 According to the above configuration, it is possible to accurately incorporate an aggregate of cells into the inner cylinder portion, and it is also easy to incorporate a desired number of cell groups into the inner cylinder portion.

上記構成において、前記複数の内筒部が含む少なくとも1つの前記第2内筒部は、前記細胞群以外の物質である液体を移送するための前記第2内筒部であって、前記第2内筒部の先端部とは反対側から、前記第2内筒部内に前記物質を取り込んでもよい。
上記構成によれば、液体の特性を生かして効率的に内筒部への対象物質の取り込みが可能である。
In the above configuration, at least one second inner cylinder portion included in the plurality of inner cylinder portions is the second inner cylinder portion for transferring a liquid which is a substance other than the cell group, and the second inner cylinder portion. The substance may be taken into the second inner cylinder portion from the side opposite to the tip end portion of the inner cylinder portion.
According to the above configuration, it is possible to efficiently take in the target substance into the inner cylinder portion by taking advantage of the characteristics of the liquid.

上記構成において、複数の前記針状部を備え、前記針状部ごとに、前記第1内筒部と前記第2内筒部とを含む複数の前記内筒部を備えてもよい。
上記構成によれば、複数の細胞群や対象物質をまとめて細胞移植装置に取り込むことや、複数の細胞群や対象物質をまとめて生体内に配置することが可能であるため、移植の効率が高められる。
In the above configuration, a plurality of the needle-shaped portions may be provided, and each of the needle-shaped portions may be provided with a plurality of the inner cylinder portions including the first inner cylinder portion and the second inner cylinder portion.
According to the above configuration, it is possible to collectively incorporate a plurality of cell groups and target substances into a cell transplantation device, and to collectively arrange a plurality of cell groups and target substances in a living body, thus improving the efficiency of transplantation. Can be enhanced.

本発明によれば、細胞群と細胞群以外の物質とを生体内に送達することができる。 According to the present invention, a cell group and a substance other than the cell group can be delivered in vivo.

細胞移植装置の一実施形態について、細胞移植装置の構成を示す図。The figure which shows the structure of the cell transplantation apparatus about one Embodiment of the cell transplantation apparatus. 一実施形態の細胞移植装置において、1つの内筒部が針状部から突き出した状態を示す図。The figure which shows the state which one inner cylinder part protruded from the needle-like part in the cell transplantation apparatus of one Embodiment. 一実施形態の細胞移植装置を用いた細胞の移植方法を示す図であって、内筒部に細胞群を取り込む工程を示す図。It is a figure which shows the cell transplantation method using the cell transplantation apparatus of one Embodiment, and is the figure which shows the step of taking in a cell group into an inner cylinder part. 一実施形態の細胞移植装置を用いた細胞の移植方法を示す図であって、内筒部とともに細胞群が針状部に収容された状態を示す図。It is a figure which shows the cell transplantation method using the cell transplantation apparatus of one Embodiment, and is the figure which shows the state which the cell group is housed in the needle-like part together with the inner cylinder part. 一実施形態の細胞移植装置を用いた細胞の移植方法を示す図であって、針状部が移植部位に刺された状態を示す図。It is a figure which shows the cell transplantation method using the cell transplantation apparatus of one Embodiment, and is the figure which shows the state which the needle-like part was stabbed in the transplantation site. 一実施形態の細胞移植装置を用いた細胞の移植方法を示す図であって、細胞群の配置工程を示す図。It is a figure which shows the cell transplantation method using the cell transplantation apparatus of one Embodiment, and is the figure which shows the arrangement process of a cell group. 一実施形態の細胞移植装置を用いた細胞の移植方法を示す図であって、補助物質の供給工程を示す図。It is a figure which shows the cell transplantation method using the cell transplantation apparatus of one Embodiment, and is the figure which shows the supply process of the auxiliary substance. 変形例の細胞移植装置の構成を示す図。The figure which shows the structure of the cell transplantation apparatus of a modified example. 変形例の細胞移植装置において、複数の内筒部が針状部から突き出した状態を示す図。The figure which shows the state which a plurality of inner cylinders protrude from a needle-like part in the cell transplantation apparatus of a modified example. 変形例の細胞移植装置の構成を示す図。The figure which shows the structure of the cell transplantation apparatus of a modified example.

図1〜図7を参照して、細胞移植装置の一実施形態を説明する。本実施形態の細胞移植装置は、生体内への細胞群の移植と細胞群以外の物質の供給とを行うために用いられる。移植の対象領域は、皮内および皮下の少なくとも一方、あるいは、臓器等の組織である。 An embodiment of the cell transplantation apparatus will be described with reference to FIGS. 1 to 7. The cell transplantation device of the present embodiment is used for transplanting a cell group into a living body and supplying a substance other than the cell group. The target area for transplantation is at least one of the intradermal and subcutaneous areas, or a tissue such as an organ.

[細胞群]
移植対象の細胞群は、複数の細胞を含む。細胞群は、凝集された複数の細胞の集合体であってもよいし、細胞間結合により結合した複数の細胞の集合体であってもよい。あるいは、細胞群は、分散した複数の細胞から構成されてもよい。また、細胞群を構成する細胞は、未分化の細胞であってもよいし、分化が完了した細胞であってもよいし、細胞群は、未分化の細胞と分化した細胞とを含んでいてもよい。細胞群は、例えば、細胞塊(スフェロイド)、原基、組織、器官、オルガノイド、ミニ臓器等である。
[Cell group]
The cell group to be transplanted includes a plurality of cells. The cell group may be an aggregate of a plurality of aggregated cells, or may be an aggregate of a plurality of cells bound by cell-cell binding. Alternatively, the cell group may be composed of a plurality of dispersed cells. Further, the cells constituting the cell group may be undifferentiated cells or cells that have been completely differentiated, and the cell group includes undifferentiated cells and differentiated cells. May be good. The cell group is, for example, a cell mass (spheroid), a primordium, a tissue, an organ, an organoid, a mini-organ, or the like.

細胞群は、対象領域に配置されることによって、生体における組織形成に作用する機能を有する。移植対象の細胞群は、例えば、皮内または皮下に配置されることにより、発毛または育毛に寄与する。こうした細胞群は、例えば、毛包器官として機能する能力、毛包器官へ分化する能力、毛包器官の形成を誘導もしくは促進する能力、毛包における毛の形成を誘導もしくは促進する能力等を有する。また、細胞群は、色素細胞もしくは色素細胞に分化する幹細胞等のように、毛色の制御に寄与する細胞を含んでいてもよい。また、細胞群は、血管系細胞を含んでいてもよい。 The cell group has a function of acting on tissue formation in a living body by being arranged in a target region. The cell group to be transplanted contributes to hair growth or hair growth by being arranged, for example, intradermally or subcutaneously. These cell groups have, for example, the ability to function as a hair follicle organ, the ability to differentiate into a hair follicle organ, the ability to induce or promote the formation of a hair follicle organ, the ability to induce or promote the formation of hair in a hair follicle, and the like. .. In addition, the cell group may include cells that contribute to the control of coat color, such as pigment cells or stem cells that differentiate into pigment cells. In addition, the cell group may include vascular cells.

具体的には、本実施形態における移植対象の細胞群の一例は、原始的な毛包器官である毛包原基である。毛包原基は、間葉系細胞と上皮系細胞とを含む。毛包器官では、間葉系細胞である毛乳頭細胞が、毛包上皮幹細胞の分化を誘導し、これによって形成された毛球部にて毛母細胞が分裂を繰り返すことにより、毛が形成される。毛包原基は、こうした毛包器官に分化する細胞群である。 Specifically, an example of the cell group to be transplanted in the present embodiment is a hair follicle primordium, which is a primitive hair follicle organ. Hair follicle primordium contains mesenchymal cells and epithelial cells. In the hair follicle organ, mesenchymal cells, the hair papilla cells, induce the differentiation of hair follicle epithelial stem cells, and the hair follicle cells repeat division in the hair follicle formed thereby to form hair. NS. Hair follicle primordium is a group of cells that differentiate into these hair follicle organs.

毛包原基は、例えば、毛乳頭等の間葉組織に由来する間葉系細胞と、バルジ領域や毛球基部等に位置する上皮組織に由来する上皮系細胞とを、所定の条件で混合培養することによって形成される。ただし、毛包原基の製造方法は上述の例に限定されない。また、毛包原基の製造に用いられる間葉系細胞と上皮系細胞との由来も限定されず、これらの細胞は、毛包器官由来の細胞であってもよいし、毛包器官とは異なる器官由来の細胞であってもよいし、多能性幹細胞から誘導された細胞であってもよい。 The hair follicle primordium is, for example, a mixture of mesenchymal cells derived from mesenchymal tissue such as the hair papilla and epithelial cells derived from epithelial tissue located in the bulge region or the base of the hair bulb under predetermined conditions. It is formed by culturing. However, the method for producing a hair follicle primordium is not limited to the above example. Further, the origin of the mesenchymal cells and epithelial cells used for producing the hair follicles primordia is not limited, and these cells may be cells derived from the hair follicles organ, or the hair follicles organs. It may be a cell derived from a different organ or a cell derived from a pluripotent stem cell.

[補助物質]
補助物質は、細胞群以外の物質であって、細胞群と共に生体内に供給される対象の物質である。補助物質は、液体であってもよいし、固体であってもよい。
[Auxiliary substance]
The auxiliary substance is a substance other than the cell group, and is a substance to be supplied into the living body together with the cell group. The auxiliary substance may be a liquid or a solid.

補助物質は、例えば、細胞群の機能の発現を補助する物質である。細胞群が毛包原基である場合、補助物質は、細胞群の毛包器官への分化あるいは当該毛包器官での毛の形成を、直接的または間接的に補助する。補助物質は、補助物質が含む成分によって、化学的または生物学的に細胞群の機能の発現を補助してもよいし、補助物質が有する形状等の構造によって、細胞群の機能の発現を補助してもよい。 Auxiliary substances are, for example, substances that assist in the expression of cell group functions. When the cell group is a hair follicle primordium, the auxiliary substance directly or indirectly assists the differentiation of the cell group into the hair follicle organ or the formation of hair in the hair follicle organ. The auxiliary substance may chemically or biologically assist the expression of the function of the cell group depending on the components contained in the auxiliary substance, or assist the expression of the function of the cell group by the structure such as the shape of the auxiliary substance. You may.

上記細胞群の機能の発現を補助する補助物質は、例えば、細胞の増殖や分化を促進する成分を含む添加剤や、移植先の組織からの細胞群の脱落を抑えるために細胞群を固定する固定剤等である。上記添加剤は、例えば、細胞の成長因子、栄養成分、サイトカイン等の生理活性物質、コラーゲン等の細胞外マトリックス等を含む。また、細胞群が発毛または育毛に寄与する場合、細胞群の働きにより毛穴の形成が好適に進行することが、良好な毛の再生のための重要な因子であると考えられている。したがって、移植対象の細胞群が毛包原基等の発毛または育毛に寄与する細胞群である場合、補助物質は、毛穴の形成のガイドとして機能する部材であってもよい。 The auxiliary substance that assists the expression of the function of the cell group is, for example, an additive containing a component that promotes cell proliferation or differentiation, or fixes the cell group in order to suppress the loss of the cell group from the tissue to be transplanted. Fixing agent, etc. The additives include, for example, cell growth factors, nutritional components, physiologically active substances such as cytokines, extracellular matrix such as collagen, and the like. Further, when the cell group contributes to hair growth or hair growth, it is considered that the favorable progress of pore formation by the action of the cell group is an important factor for good hair regeneration. Therefore, when the cell group to be transplanted is a cell group such as a hair follicle primordium that contributes to hair growth or hair growth, the auxiliary substance may be a member that functions as a guide for the formation of pores.

また、補助物質は、細胞移植装置が備える針状部の生体内への進入や引抜を補助する物質であってもよい。こうした補助物質は、例えば、生体内への針状部の刺し抜きによる痛みの発生を抑える物質や、生体と針状部との間の摩擦を抑える潤滑剤である。 Further, the auxiliary substance may be a substance that assists the entry or withdrawal of the needle-shaped portion of the cell transplantation device into the living body. Such auxiliary substances are, for example, a substance that suppresses the occurrence of pain due to piercing the needle-shaped portion into the living body, and a lubricant that suppresses friction between the living body and the needle-shaped portion.

[細胞移植装置の構成]
図1および図2を参照して、細胞移植装置の構成を説明する。
図1が示すように、細胞移植装置100は、1つの方向に沿って延びる筒状の針状部20と、針状部20の内側に位置する複数の内筒部30とを備える。
[Structure of cell transplantation device]
The configuration of the cell transplantation apparatus will be described with reference to FIGS. 1 and 2.
As shown in FIG. 1, the cell transplantation device 100 includes a tubular needle-shaped portion 20 extending along one direction and a plurality of inner tubular portions 30 located inside the needle-shaped portion 20.

針状部20は、針先部10と収容部15とを有している。針先部10と収容部15とは、針状部20の延びる方向に沿って並び、針先部10の内部空間と収容部15の内部空間とは互いに連通している。 The needle-shaped portion 20 has a needle tip portion 10 and an accommodating portion 15. The needle tip portion 10 and the accommodating portion 15 are arranged along the extending direction of the needle-shaped portion 20, and the internal space of the needle tip portion 10 and the internal space of the accommodating portion 15 communicate with each other.

針先部10は、針状部20の先端を含む。針先部10は、先端部に開口部11を有している。すなわち、開口部11は、針状部20の先端部に位置する。針先部10の形状は、円筒や角筒の筒状であって、その先端部が、生体における移植の対象の部位を刺すことの可能な外形を有していれば特に限定されない。針先部10の先端部は、例えば、円筒をその延びる方向に対して斜めに切断した形状を有し、尖っている。 The needle tip portion 10 includes the tip of the needle-shaped portion 20. The needle tip portion 10 has an opening 11 at the tip end portion. That is, the opening 11 is located at the tip of the needle-shaped portion 20. The shape of the needle tip portion 10 is not particularly limited as long as it has a cylindrical shape such as a cylinder or a square cylinder and the tip portion has an outer shape capable of piercing a site to be transplanted in a living body. The tip of the needle tip 10 has, for example, a shape in which the cylinder is cut diagonally with respect to the extending direction thereof, and is sharp.

収容部15は、複数の内筒部30を収容している。収容部15の形状は、複数の内筒部30を収容可能な形状であれば、特に限定されない。例えば、収容部15は、円筒形状を有していてもよいし、角筒形状を有していてもよい。 The accommodating portion 15 accommodates a plurality of inner cylinder portions 30. The shape of the accommodating portion 15 is not particularly limited as long as it can accommodate a plurality of inner cylinder portions 30. For example, the accommodating portion 15 may have a cylindrical shape or a square tubular shape.

内筒部30は、針状部20の延びる方向に沿って延びる筒状を有する。例えば、内筒部30は、円筒形状を有していてもよいし、角筒形状を有していてもよい。内筒部30は、細胞群または補助物質である移送対象を取り込んで放出する機能を有する。複数の内筒部30のうち、1つの内筒部30の移送対象は細胞群であり、残りの内筒部30の移送対象は補助物質である。 The inner cylinder portion 30 has a tubular shape extending along the extending direction of the needle-shaped portion 20. For example, the inner cylinder portion 30 may have a cylindrical shape or a square cylinder shape. The inner cylinder portion 30 has a function of taking in and releasing a transfer target which is a cell group or an auxiliary substance. Of the plurality of inner cylinders 30, the transfer target of one inner cylinder 30 is a cell group, and the transfer target of the remaining inner cylinder 30 is an auxiliary substance.

内筒部30は、細胞群を移送するための内筒部30である1つの第1内筒部と、補助物質を移送するための内筒部30である1以上の第2内筒部とを含む。第2内筒部の数は特に限定されない。本実施形態では、一例として、第1内筒部である内筒部30aと、第2筒部である内筒部30bおよび内筒部30cとの3つの内筒部30を細胞移植装置100が備える形態を説明する。 The inner cylinder portion 30 includes one first inner cylinder portion which is an inner cylinder portion 30 for transferring a cell group, and one or more second inner cylinder portions which are inner cylinder portions 30 for transferring an auxiliary substance. including. The number of the second inner cylinders is not particularly limited. In the present embodiment, as an example, the cell transplantation apparatus 100 has three inner cylinder portions 30 of the inner cylinder portion 30a which is the first inner cylinder portion and the inner cylinder portion 30b and the inner cylinder portion 30c which are the second cylinder portions. The form to be provided will be described.

複数の内筒部30において、内筒部30の形状は同一であってもよいし、同一でなくてもよい。また、複数の内筒部30において、内筒部30の内径は一定であってもよいし、一定でなくてもよい。各内筒部30の形状および内径は、内筒部30ごとの移送対象に応じて定められていればよい。 In the plurality of inner cylinder portions 30, the shape of the inner cylinder portion 30 may or may not be the same. Further, in the plurality of inner cylinder portions 30, the inner diameter of the inner cylinder portion 30 may or may not be constant. The shape and inner diameter of each inner cylinder portion 30 may be determined according to the transfer target for each inner cylinder portion 30.

収容部15の内径は、針先部10の内径よりも大きい。収容部15は、すべての内筒部30をまとめて収容可能な大きさの内径を有する。針先部10は、複数の内筒部30を1つずつ通すことの可能な大きさの内径を有する。すなわち、針先部10の内径は、複数の内筒部30のうちの最大の内径よりも大きい。 The inner diameter of the accommodating portion 15 is larger than the inner diameter of the needle tip portion 10. The accommodating portion 15 has an inner diameter large enough to accommodate all the inner cylinder portions 30 together. The needle tip portion 10 has an inner diameter large enough to allow a plurality of inner cylinder portions 30 to pass through one by one. That is, the inner diameter of the needle tip portion 10 is larger than the maximum inner diameter of the plurality of inner cylinder portions 30.

細胞移植装置100は、さらに、駆動部40および移送制御部41を備えている。駆動部40は、複数の内筒部30を、内筒部30ごとに、針状部20の延びる方向に大まかに沿った方向に動かす。詳細には、駆動部40は、内筒部30の先端部が針状部20の内部に位置した状態と、内筒部30の先端部が針先部10の開口部11から突き出した状態との間で、内筒部30を針状部20に対して相対的に動かす。図2は、内筒部30aの先端部が開口部11から突き出している状態を示す。 The cell transplantation device 100 further includes a drive unit 40 and a transfer control unit 41. The drive unit 40 moves a plurality of inner cylinder portions 30 in a direction roughly along the extending direction of the needle-shaped portion 20 for each inner cylinder portion 30. Specifically, the drive unit 40 has a state in which the tip portion of the inner cylinder portion 30 is located inside the needle-shaped portion 20 and a state in which the tip portion of the inner cylinder portion 30 protrudes from the opening 11 of the needle tip portion 10. The inner cylinder portion 30 is moved relative to the needle-shaped portion 20 between the two. FIG. 2 shows a state in which the tip end portion of the inner cylinder portion 30a protrudes from the opening portion 11.

なお、複数の内筒部30の配列は、複数の内筒部30について1つずつその先端部を開口部11から出し入れすることが可能であれば、限定されない。例えば、複数の内筒部30は、収容部15の周方向に沿って環状に並んでいてもよいし、収容部15の径方向に沿って直線状に並んでいてもよい。 The arrangement of the plurality of inner cylinder portions 30 is not limited as long as the tip portions of the plurality of inner cylinder portions 30 can be taken in and out from the opening 11 one by one. For example, the plurality of inner cylinder portions 30 may be arranged in an annular shape along the circumferential direction of the accommodating portion 15, or may be arranged linearly along the radial direction of the accommodating portion 15.

駆動部40は、複数の内筒部30を互いに独立して、すなわち、各内筒部30を別々に動かす。例えば、駆動部40は、バネやバネを押圧する押圧部材等の部品を含み、ユーザーの操作に基づきこれらの部品の連動によって、各内筒部30を動かす機構であってもよいし、モーター等の電子部品を含み、ユーザーの指示に基づく電子制御によって、各内筒部30を動かすように構成されていてもよい。 The drive unit 40 moves the plurality of inner cylinder portions 30 independently of each other, that is, moves each inner cylinder portion 30 separately. For example, the drive unit 40 may be a mechanism that includes parts such as a spring and a pressing member that presses the spring, and moves each inner cylinder portion 30 by interlocking these parts based on a user's operation, a motor, or the like. Each inner cylinder portion 30 may be configured to move by electronic control based on a user's instruction, including the electronic component of the above.

移送制御部41は、内筒部30における移送対象の取り込みおよび放出を制御する。具体的には、移送制御部41は、内筒部30内の吸引や加圧を利用して、内筒部30における移送対象の保持状態を制御することが好ましい。 The transfer control unit 41 controls the uptake and release of the transfer target in the inner cylinder unit 30. Specifically, it is preferable that the transfer control unit 41 controls the holding state of the transfer target in the inner cylinder portion 30 by utilizing suction or pressurization in the inner cylinder portion 30.

移送対象が液体以外である場合、すなわち、移送対象が、細胞群、固形状の添加剤、ガイド等の部材である場合、移送制御部41が内筒部30内を吸引することによって、内筒部30の先端部の開口から移送対象が内筒部30の内部に取り込まれる。そして、移送制御部41が内筒部30内を加圧することによって、移送対象が内筒部30の先端部の開口から放出されて、生体内に配置される。 When the transfer target is other than a liquid, that is, when the transfer target is a member such as a cell group, a solid additive, or a guide, the transfer control unit 41 sucks the inside of the inner cylinder portion 30 to cause the inner cylinder. The transfer target is taken into the inner cylinder portion 30 through the opening at the tip portion of the portion 30. Then, when the transfer control unit 41 pressurizes the inside of the inner cylinder portion 30, the transfer target is released from the opening of the tip portion of the inner cylinder portion 30 and arranged in the living body.

あるいは、移送制御部41が内筒部30内を吸引することによって、内筒部30の先端部の外側に移送対象が保持されてもよい。この場合、内筒部30の先端部の内径は、移送対象の径よりも小さく、移送対象は、内筒部30の先端部に当接した状態で、内筒部30に保持される。そして、移送制御部41による内筒部30内の吸引の停止、もしくは、内筒部30内の加圧によって、内筒部30における移送対象の保持が解除され、移送対象は生体内に配置される。 Alternatively, the transfer target may be held outside the tip of the inner cylinder 30 by the transfer control unit 41 sucking the inside of the inner cylinder 30. In this case, the inner diameter of the tip of the inner cylinder 30 is smaller than the diameter of the transfer target, and the transfer target is held by the inner cylinder 30 in a state of being in contact with the tip of the inner cylinder 30. Then, the holding of the transfer target in the inner cylinder portion 30 is released by the stop of suction in the inner cylinder portion 30 by the transfer control unit 41 or the pressurization in the inner cylinder portion 30, and the transfer target is arranged in the living body. NS.

移送対象が液体である場合、移送制御部41が、例えば、内筒部30の先端部とは反対側から、内筒部30内に移送対象を送り込むことにより、内筒部30に移送対象が取り込まれる。さらに、移送制御部41が内筒部30内を加圧することによって、内筒部30の先端部の開口から移送対象が放出されて、生体内に配置される。内筒部30内の加圧は、ピストン等の押圧部材によって行われてもよいし、移送対象と同じ液体の更なる注入によって行われてもよい。 When the transfer target is a liquid, the transfer control unit 41 sends the transfer target into the inner cylinder portion 30 from the side opposite to the tip portion of the inner cylinder portion 30, so that the transfer target is transferred to the inner cylinder portion 30. It is captured. Further, when the transfer control unit 41 pressurizes the inside of the inner cylinder portion 30, the transfer target is released from the opening of the tip portion of the inner cylinder portion 30 and arranged in the living body. The pressurization in the inner cylinder portion 30 may be performed by a pressing member such as a piston, or may be performed by further injecting the same liquid as the transfer target.

あるいは、移送制御部41が内筒部30内を吸引することにより、内筒部30の先端部の開口から移送対象が内筒部30の内部に取り込まれてもよい。そして、移送制御部41が内筒部30内を加圧することにより、内筒部30の先端部の開口から移送対象が放出されて、生体内に配置される。 Alternatively, the transfer control unit 41 may suck the inside of the inner cylinder portion 30, so that the transfer target may be taken into the inside of the inner cylinder portion 30 from the opening of the tip portion of the inner cylinder portion 30. Then, when the transfer control unit 41 pressurizes the inside of the inner cylinder portion 30, the transfer target is released from the opening of the tip portion of the inner cylinder portion 30 and is arranged in the living body.

移送制御部41は、例えば、ピストン等の部品を含み、ユーザーの操作に応じた部品の動きによって、内筒部30内の加圧や吸引を行う機構であってもよいし、モーター等の電子部品を含み、ユーザーの指示に基づく電子制御によって、内筒部30内の加圧や吸引を行うように構成されていてもよい。 The transfer control unit 41 may be, for example, a mechanism that includes parts such as a piston and pressurizes or sucks the inside of the inner cylinder portion 30 by the movement of the parts according to the operation of the user, or an electron such as a motor. It may be configured to pressurize or suck the inside of the inner cylinder portion 30 by electronic control based on a user's instruction including parts.

なお、針状部20および内筒部30の材料は特に限定されない。針状部20は、例えば、シリコンや、ステンレス、チタン、コバルトクロム合金、マグネシウム等などの金属材料や、汎用のプラスチック、医療用のプラスチック、化粧品用のプラスチック等の高分子材料から形成される。高分子材料としては、例えば、ポリエチレン、ポリプロピレン、ポリスチレン、ポリアミド、ポリカーボネート、環状ポリオレフィン、ポリ乳酸、ポリグリコール酸、ポリカプロラクトン、アクリル、ウレタン樹脂、芳香族ポリエーテルケトン、エポキシ樹脂、および、これらの樹脂の共重合材料等が挙げられる。また、針状部20は、ポリアクリルなどの電離放射線硬化型材料や、ウレタンやエポキシ等の熱硬化型材料から形成されてもよい。針先部10と収容部15とは、同一の材料から成形されていてもよいし、互いに異なる材料から形成されていてもよい。 The materials of the needle-shaped portion 20 and the inner cylinder portion 30 are not particularly limited. The needle-shaped portion 20 is formed of, for example, a metal material such as silicon, stainless steel, titanium, cobalt-chromium alloy, magnesium, or a polymer material such as general-purpose plastic, medical plastic, or cosmetic plastic. Examples of the polymer material include polyethylene, polypropylene, polystyrene, polyamide, polycarbonate, cyclic polyolefin, polylactic acid, polyglycolic acid, polycaprolactone, acrylic, urethane resin, aromatic polyetherketone, epoxy resin, and resins thereof. Examples include the copolymerization material of. Further, the needle-shaped portion 20 may be formed of an ionizing radiation curable material such as polyacrylic or a thermosetting material such as urethane or epoxy. The needle tip portion 10 and the accommodating portion 15 may be formed of the same material or may be formed of different materials.

内筒部30は、例えば、上述の針状部20の材料として例示した材料から形成される。針状部20と内筒部30とは、同一の材料から成形されていてもよいし、互いに異なる材料から形成されていてもよい。また、複数の内筒部30は、すべてが同じ材料から形成されている必要はない。また、針状部20および内筒部30の各々は、2種類以上の材料の組み合わせによって形成されていてもよい。 The inner cylinder portion 30 is formed of, for example, a material exemplified as the material of the needle-shaped portion 20 described above. The needle-shaped portion 20 and the inner cylinder portion 30 may be formed of the same material or may be formed of different materials. Further, the plurality of inner cylinder portions 30 do not have to be all formed of the same material. Further, each of the needle-shaped portion 20 and the inner cylinder portion 30 may be formed by a combination of two or more kinds of materials.

[移植方法]
細胞移植装置100を用いた細胞群の移植方法を説明する。以下では、例として、細胞群と、二種類の液体の補助物質とを、生体内に送達する場合を説明する。
[Porting method]
A method of transplanting a cell group using the cell transplantation device 100 will be described. In the following, as an example, a case where a cell group and two kinds of liquid auxiliary substances are delivered into a living body will be described.

図3が示すように、移植前において、細胞群Cgは、培養容器等のトレイ50に保護液Plと共に保持されている。例えば、図3が示すように、細胞群Cgと保護液Plとは、トレイ50が有する凹部51に入れられている。トレイ50における細胞群Cgと保護液Plとの保持態様は、凹部51に細胞群Cgと保護液Plとが保持される形態に限らず、例えば、トレイ50が有する平面上に細胞群Cgと保護液Plとが配置されていてもよい。また、トレイ50は、培養容器とは異なる容器であって、培養容器からトレイ50に細胞群Cgが移されてもよい。 As shown in FIG. 3, before transplantation, the cell group Cg is held in a tray 50 such as a culture vessel together with the protective solution Pl. For example, as shown in FIG. 3, the cell group Cg and the protective liquid Pl are placed in the recess 51 of the tray 50. The holding mode of the cell group Cg and the protective liquid Pl in the tray 50 is not limited to the form in which the cell group Cg and the protective liquid Pl are held in the recess 51, and for example, the cell group Cg and the protective liquid Pl are protected on the plane of the tray 50. The liquid Pl may be arranged. Further, the tray 50 is a container different from the culture container, and the cell group Cg may be transferred from the culture container to the tray 50.

保護液Plは、細胞の生存を阻害し難い液体であればよく、また、生体に注入された場合に生体に与える影響の小さい液体であることが好ましい。例えば、保護液Plは、生理食塩水、ワセリンや化粧水等の皮膚を保護する液体、あるいは、これらの液体の混合物である。保護液Plは、栄養成分等の添加成分を含んでいてもよい。また、トレイ50が培養容器であって、細胞群Cgがトレイ50にて培養される場合、保護液Plは、細胞の培養のための培地であってもよいし、培地から交換された液体であってもよい。細胞群Cgと保護液Plとを含む液状体は、低粘度の流体、あるいは、高粘度の流体であり得る。 The protective liquid Pl may be any liquid that does not easily inhibit the survival of cells, and is preferably a liquid that has a small effect on the living body when injected into the living body. For example, the protective liquid Pl is a liquid that protects the skin such as physiological saline, petrolatum, and a lotion, or a mixture of these liquids. The protective liquid Pl may contain an additive component such as a nutritional component. When the tray 50 is a culture vessel and the cell group Cg is cultured in the tray 50, the protective liquid Pl may be a medium for culturing cells, or may be a liquid exchanged from the medium. There may be. The liquid containing the cell group Cg and the protective solution Pl can be a low-viscosity fluid or a high-viscosity fluid.

まず、駆動部40の動作により、細胞群Cgを移送対象とする内筒部30aが動かされ、内筒部30aの先端部が針先部10の開口部11から突き出た状態とされる。そして、針先部10の先端部および内筒部30aの先端部が、保護液Pl中の細胞群Cgに近づけられ、移送制御部41により内筒部30a内が吸引される。これにより、細胞群Cgが内筒部30aの先端部に引き寄せられ、内筒部30aの先端部の開口から、細胞群Cgが保護液Plと共に内筒部30aの内部に取り込まれる。 First, the operation of the drive unit 40 moves the inner cylinder portion 30a to which the cell group Cg is to be transferred, and the tip portion of the inner cylinder portion 30a is in a state of protruding from the opening 11 of the needle tip portion 10. Then, the tip of the needle tip 10 and the tip of the inner cylinder 30a are brought close to the cell group Cg in the protective liquid Pl, and the inside of the inner cylinder 30a is sucked by the transfer control unit 41. As a result, the cell group Cg is attracted to the tip of the inner cylinder 30a, and the cell group Cg is taken into the inner cylinder 30a together with the protective liquid Pl from the opening of the tip of the inner cylinder 30a.

その後、図4が示すように、内筒部30aが動かされることによって、内筒部30aの先端部が針状部20の内部に引き込まれ、これに伴って、細胞群Cgも針状部20の内部に収容される。細胞群Cgの保護のためには、針先部10の内部において、細胞群Cgは保護液Plで取り囲まれていることが好ましい。 After that, as shown in FIG. 4, by moving the inner cylinder portion 30a, the tip portion of the inner cylinder portion 30a is pulled into the needle-shaped portion 20, and along with this, the cell group Cg also becomes the needle-shaped portion 20. It is housed inside. In order to protect the cell group Cg, it is preferable that the cell group Cg is surrounded by the protective solution Pl inside the needle tip portion 10.

なお、内筒部30aは、内筒部30aの先端部が針状部20の内部に配置される位置まで動かされればよい。図4が示すように、内筒部30aの先端部は、針先部10の内部に位置してもよいし、あるいは、内筒部30aが収容部15の内部まで引き込まれ、内筒部30aの先端部は、収容部15の内部に位置してもよい。 The inner cylinder portion 30a may be moved to a position where the tip end portion of the inner cylinder portion 30a is arranged inside the needle-shaped portion 20. As shown in FIG. 4, the tip end portion of the inner cylinder portion 30a may be located inside the needle tip portion 10, or the inner cylinder portion 30a is pulled into the inside of the accommodating portion 15 and the inner cylinder portion 30a is drawn. The tip of the may be located inside the accommodating portion 15.

細胞群Cgを収容した細胞移植装置100が、生体の例えば皮膚Skである移植部位まで運ばれ、図5が示すように、移植部位に針先部10が刺される。このとき、内筒部30aの先端部は、針状部20の内部に位置するため、細胞移植装置100の先端部には、針先部10の先端部が位置する。針先部10の先端部は生体に刺さりやすい形状を有しているため、細胞移植装置100は移植部位に円滑に進入できる。なお、針先部10は、移植部位の表面に対して直交する方向に移植部位に進入してもよいし、移植部位の表面に対して傾斜した方向に移植部位に進入してもよい。 The cell transplantation device 100 accommodating the cell group Cg is carried to a transplantation site such as a skin Sk in a living body, and as shown in FIG. 5, the needle tip portion 10 is pierced at the transplantation site. At this time, since the tip portion of the inner cylinder portion 30a is located inside the needle-shaped portion 20, the tip portion of the needle tip portion 10 is located at the tip portion of the cell transplantation device 100. Since the tip of the needle tip 10 has a shape that easily sticks into the living body, the cell transplant device 100 can smoothly enter the transplant site. The needle tip portion 10 may enter the transplantation site in a direction orthogonal to the surface of the transplantation site, or may enter the transplantation site in a direction inclined with respect to the surface of the transplantation site.

針先部10の先端部が移植の対象領域まで進入すると、内筒部30aが動かされ、内筒部30aの先端部が針先部10の開口部11から突き出た状態とされる。そして、図6が示すように、内筒部30a内が加圧されることにより、細胞群Cgと保護液Plとが、内筒部30aの先端部の開口から放出されて、移植の対象領域に配置される。 When the tip of the needle tip 10 enters the target area for transplantation, the inner cylinder 30a is moved so that the tip of the inner cylinder 30a protrudes from the opening 11 of the needle tip 10. Then, as shown in FIG. 6, by pressurizing the inside of the inner cylinder portion 30a, the cell group Cg and the protective liquid Pl are released from the opening of the tip portion of the inner cylinder portion 30a, and the target region for transplantation is formed. Is placed in.

なお、内筒部30aの先端部が開口部11から突き出た状態とされる際には、針先部10が移植部位から抜かれる方向に針状部20がやや後退させられ、移植部位の内部において、針先部10の先端部が位置していた空間に、内筒部30aの先端部が配置されてもよい。そして、針先部10の先端部が位置していた空間に、細胞群Cgが放出されてもよい。これにより、細胞群Cgが内筒部30aから出るときに周囲の組織から押圧されて細胞群Cgに負荷がかかることが抑えられる。
移植の対象領域に細胞群Cgが配置されると、内筒部30aが動かされて収容部15の内部まで引き込まれる。
When the tip of the inner cylinder portion 30a is in a state of protruding from the opening 11, the needle-shaped portion 20 is slightly retracted in the direction in which the needle tip portion 10 is pulled out from the transplant site, and the inside of the transplant site is formed. In the space where the tip end portion of the needle tip portion 10 was located, the tip end portion of the inner cylinder portion 30a may be arranged. Then, the cell group Cg may be released into the space where the tip of the needle tip 10 is located. As a result, when the cell group Cg exits the inner cylinder portion 30a, it is suppressed from being pressed by the surrounding tissues and the cell group Cg being loaded.
When the cell group Cg is placed in the target area for transplantation, the inner cylinder portion 30a is moved and pulled into the inside of the containment portion 15.

続いて、図7が示すように、駆動部40の動作により、補助物質を移送対象とする内筒部30bが動かされ、内筒部30bの先端部が針先部10の開口部11から突き出た状態とされる。そして、移送制御部41により、内筒部30bの先端部とは反対側から、補助物質である添加液Slが内筒部30bの内部に流し込まれる。添加液Slは内筒部30bの内部を通って内筒部30bの先端部の開口から出る。その結果、移植の対象領域に配置されている細胞群Cgの周囲に添加液Slが供給される。所定量の添加液Slが細胞群Cgの付近に供給されると、内筒部30bへの添加液Slの供給が停止され、内筒部30bが動かされて収容部15の内部まで引き込まれる。 Subsequently, as shown in FIG. 7, the operation of the drive unit 40 moves the inner cylinder portion 30b to which the auxiliary substance is transferred, and the tip portion of the inner cylinder portion 30b protrudes from the opening 11 of the needle tip portion 10. It is said that it is in a state of being. Then, the transfer control unit 41 pours the additive liquid Sl, which is an auxiliary substance, into the inner cylinder portion 30b from the side opposite to the tip portion of the inner cylinder portion 30b. The additive liquid Sl passes through the inside of the inner cylinder portion 30b and exits from the opening at the tip portion of the inner cylinder portion 30b. As a result, the additive solution Sl is supplied around the cell group Cg arranged in the target region for transplantation. When a predetermined amount of the additive liquid Sl is supplied in the vicinity of the cell group Cg, the supply of the additive liquid Sl to the inner cylinder portion 30b is stopped, and the inner cylinder portion 30b is moved and drawn into the inside of the accommodating portion 15.

なお、図7においては、内筒部30bが直線状に延びた状態で開口部11から突出する形態を例示しているが、内筒部30bは、柔軟性を有し、例えば移動の過程で撓むように変形しつつ、開口部11から出し入れされてもよい。内筒部30a,30cについても同様である。 Note that FIG. 7 illustrates a form in which the inner cylinder portion 30b protrudes from the opening 11 in a linearly extended state, but the inner cylinder portion 30b has flexibility and is, for example, in the process of movement. It may be taken in and out of the opening 11 while being deformed so as to bend. The same applies to the inner cylinder portions 30a and 30c.

続いて、補助物質を移送対象とする内筒部30cについても、上述の内筒部30bと同様の動作が繰り返される。すなわち、内筒部30cの先端部が針先部10の開口部11から突き出る位置まで内筒部30cが動かされ、移送制御部41により、内筒部30cの先端部と反対側から、補助物質である液体が内筒部30bの内部に流し込まれる。内筒部30cに供給される補助物質は、内筒部30bに供給された補助物質とは異なる物質である。 Subsequently, the same operation as the above-mentioned inner cylinder portion 30b is repeated for the inner cylinder portion 30c to which the auxiliary substance is transferred. That is, the inner cylinder portion 30c is moved to a position where the tip portion of the inner cylinder portion 30c protrudes from the opening 11 of the needle tip portion 10, and the transfer control unit 41 moves the auxiliary substance from the side opposite to the tip portion of the inner cylinder portion 30c. The liquid is poured into the inner cylinder portion 30b. The auxiliary substance supplied to the inner cylinder portion 30c is a substance different from the auxiliary substance supplied to the inner cylinder portion 30b.

これにより、内筒部30cの内部を通って補助物質が内筒部30cの先端部の開口から放出され、細胞群Cgの周囲に供給される。所定量の補助物質が細胞群Cgの付近に供給されると、内筒部30cへの補助物質の供給が停止され、内筒部30bが動かされて収容部15の内部まで引き込まれる。 As a result, the auxiliary substance is released from the opening at the tip of the inner cylinder portion 30c through the inside of the inner cylinder portion 30c and is supplied around the cell group Cg. When a predetermined amount of the auxiliary substance is supplied in the vicinity of the cell group Cg, the supply of the auxiliary substance to the inner cylinder portion 30c is stopped, and the inner cylinder portion 30b is moved and pulled into the inside of the accommodating portion 15.

その後、針先部10は、移植部位から引き抜かれる。なお、内筒部30cが収容部15の内部に収容されず、針先部10の開口部11から内筒部30cの先端部が突き出た状態で、針先部10が移植部位から引き抜かれてもよい。 After that, the needle tip portion 10 is pulled out from the transplantation site. The needle tip portion 10 is pulled out from the transplantation site in a state where the inner cylinder portion 30c is not accommodated inside the accommodating portion 15 and the tip portion of the inner cylinder portion 30c protrudes from the opening 11 of the needle tip portion 10. May be good.

以上により、細胞群Cgの対象領域への移植と、補助物質の供給とが完了する。本実施形態によれば、細胞移植装置100が、細胞群Cgを移送するための内筒部30と、補助物質を移送するための内筒部30とを備えているため、細胞群Cgに加えて、補助物質を細胞移植装置100の内部に取り込むことができる。そして、針先部10が移植の対象領域に刺さった状態において、各内筒部30が1つの針先部10の開口部11から順に突出して移送対象を生体内に放出するため、生体内において細胞群Cgが配置された領域の付近に補助物質を配置することができる。したがって、細胞群Cgと補助物質と生体内に容易に送達することができる。
特に、細胞移植装置100は、補助物質が、細胞群Cgを生体内に配置するタイミングと合わせて生体内に送り込むことが望まれる物質である場合に、好適に用いられる。
As described above, the transplantation of the cell group Cg into the target region and the supply of the auxiliary substance are completed. According to the present embodiment, since the cell transplantation device 100 includes an inner cylinder portion 30 for transferring the cell group Cg and an inner cylinder portion 30 for transferring the auxiliary substance, it is added to the cell group Cg. Therefore, the auxiliary substance can be taken into the cell transplantation device 100. Then, in a state where the needle tip portion 10 is stuck in the target region for transplantation, each inner cylinder portion 30 protrudes in order from the opening 11 of one needle tip portion 10 and releases the transfer target into the living body. Auxiliary substances can be placed near the region where the cell group Cg is placed. Therefore, the cell group Cg, the auxiliary substance, and the in vivo can be easily delivered.
In particular, the cell transplantation device 100 is preferably used when the auxiliary substance is a substance that is desired to be delivered into the living body at the timing of arranging the cell group Cg in the living body.

補助物質が、細胞群Cgの機能の発現を補助する物質である場合、細胞移植装置100を用いて細胞群Cgおよび補助物質を生体内に送達することにより、細胞群Cgの機能が発現しやすくなる。例えば、細胞群Cgが、毛包原基のように、発毛または育毛に寄与する細胞群である場合、毛の形成が好適に進む。したがって、細胞移植装置100は、例えば、確実に毛を発生させたい箇所への細胞群Cgへの移植に好適に用いられる。 When the auxiliary substance is a substance that assists the expression of the function of the cell group Cg, the function of the cell group Cg is likely to be expressed by delivering the cell group Cg and the auxiliary substance into the living body using the cell transplantation device 100. Become. For example, when the cell group Cg is a cell group that contributes to hair growth or hair growth, such as a hair follicle primordium, hair formation preferably proceeds. Therefore, the cell transplantation device 100 is suitably used, for example, for transplantation into the cell group Cg to a place where hair is surely to be generated.

また、補助物質が、針状部20の生体内への進入や引抜を補助する物質である場合、細胞移植装置100を用いて細胞群Cgおよび補助物質を生体内に送達することにより、針状部20の生体内への刺し抜きが円滑に進められる。 When the auxiliary substance is a substance that assists the entry or withdrawal of the needle-shaped portion 20 into the living body, the cell group Cg and the auxiliary substance are delivered into the living body by using the cell transplantation device 100 to form a needle-shaped part. The piercing of the part 20 into the living body is smoothly proceeded.

なお、上記移植方法の説明においては、最初に細胞群Cgを生体内に移植し、その後に補助物質を供給したが、細胞群Cgと補助物質との送達の順序は特に限定されない。補助物質を供給した後に細胞群Cgを移植してもよいし、複数の補助物質の供給の間に細胞群Cgを移植してもよい。 In the above description of the transplantation method, the cell group Cg was first transplanted into the living body, and then the auxiliary substance was supplied, but the order of delivery of the cell group Cg and the auxiliary substance is not particularly limited. The cell group Cg may be transplanted after the auxiliary substance is supplied, or the cell group Cg may be transplanted between the supply of the plurality of auxiliary substances.

また、上記移植方法の説明においては、針先部10を生体に刺した後に、補助物質を内筒部30内に供給したが、針先部10を生体に刺す前に、補助物質を内筒部30内に充填してもよい。この場合、生体内への補助物質の供給に際しては、補助物質が充填された内筒部30の先端部が、生体に刺された針先部10の開口部11から突き出された後に、内筒部30内が加圧される。これにより、内筒部30内の補助物質が内筒部30の先端部から生体内に放出される。 Further, in the above description of the transplantation method, the auxiliary substance is supplied into the inner cylinder portion 30 after the needle tip portion 10 is pierced into the living body, but the auxiliary substance is applied to the inner cylinder portion before the needle tip portion 10 is pierced into the living body. The portion 30 may be filled. In this case, when supplying the auxiliary substance into the living body, the tip of the inner cylinder portion 30 filled with the auxiliary substance is projected from the opening 11 of the needle tip portion 10 pierced by the living body, and then the inner cylinder portion. The inside of 30 is pressurized. As a result, the auxiliary substance in the inner cylinder portion 30 is released into the living body from the tip portion of the inner cylinder portion 30.

また、補助物質が液体である場合には、先に述べたように、内筒部30の先端部の開口から、補助物質が内筒部30の内部に取り込まれてもよい。例えば、内筒部30bについて、その先端部から補助物質を取り込ませる場合、細胞群Cgをトレイ50から内筒部30a内に取り込む前もしくは後に、内筒部30bをその先端部が針先部10の開口部11から突き出した状態とし、補助物質が入った容器内に内筒部30bの先端部を差し入れて、内筒部30b内を吸引する。これにより、内筒部30bの先端部から補助物質が内筒部30b内に取り込まれる。生体内への補助物質の供給に際しては、内筒部30bの先端部が、生体に刺された針先部10の開口部11から突き出された状態で、内筒部30b内が加圧される。これにより、内筒部30b内の補助物質が内筒部30bの先端部から生体内に放出される。 Further, when the auxiliary substance is a liquid, as described above, the auxiliary substance may be taken into the inside of the inner cylinder portion 30 through the opening of the tip portion of the inner cylinder portion 30. For example, when an auxiliary substance is taken in from the tip of the inner cylinder 30b, the tip of the inner cylinder 30b is the needle tip 10 before or after the cell group Cg is taken into the inner cylinder 30a from the tray 50. The tip of the inner cylinder portion 30b is inserted into the container containing the auxiliary substance, and the inside of the inner cylinder portion 30b is sucked. As a result, the auxiliary substance is taken into the inner cylinder portion 30b from the tip portion of the inner cylinder portion 30b. When supplying the auxiliary substance into the living body, the inside of the inner cylinder portion 30b is pressurized with the tip of the inner cylinder portion 30b protruding from the opening 11 of the needle tip portion 10 pierced by the living body. As a result, the auxiliary substance in the inner cylinder portion 30b is released into the living body from the tip portion of the inner cylinder portion 30b.

また、補助物質が液体以外である場合、細胞群Cgの取り込みと同様に、補助物質が取り込まれる。例えば、内筒部30bに液体以外の補助物質を保持させる場合、細胞群Cgをトレイ50から内筒部30aに取り込む前もしくは後に、内筒部30bをその先端部が針先部10の開口部11から突き出した状態とし、内筒部30bの先端部を補助物質に近づけて、内筒部30b内を吸引する。これにより、内筒部30bの先端部の開口から補助物質が内筒部30bの内部に取り込まれる。生体内への補助物質の供給に際しては、内筒部30bの先端部が、生体に刺された針先部10の開口部11から突き出された状態で、内筒部30内が加圧される。これにより、内筒部30内の補助物質が内筒部30の先端部から放出されて生体内に配置される。 When the auxiliary substance is other than a liquid, the auxiliary substance is taken up in the same manner as the uptake of the cell group Cg. For example, when the inner cylinder portion 30b holds an auxiliary substance other than a liquid, the tip portion of the inner cylinder portion 30b is the opening of the needle tip portion 10 before or after the cell group Cg is taken into the inner cylinder portion 30a from the tray 50. With the state protruding from 11, the tip portion of the inner cylinder portion 30b is brought close to the auxiliary substance, and the inside of the inner cylinder portion 30b is sucked. As a result, the auxiliary substance is taken into the inside of the inner cylinder portion 30b from the opening of the tip portion of the inner cylinder portion 30b. When supplying the auxiliary substance into the living body, the inside of the inner cylinder portion 30 is pressurized with the tip of the inner cylinder portion 30b protruding from the opening 11 of the needle tip portion 10 pierced by the living body. As a result, the auxiliary substance in the inner cylinder portion 30 is released from the tip portion of the inner cylinder portion 30 and placed in the living body.

また、補助物質が液体以外である場合、先に述べたように、内筒部30内の吸引によって、内筒部30の先端部の外側に補助物質が保持されてもよい。ただし、細胞移植装置100を移植部位まで移動させるときに、針状部20内で補助物質同士の接触や補助物質と細胞群Cgとの接触が起きることを抑えるためには、補助物質が液体以外である場合にも、補助物質は内筒部30の内部に取り込まれることが好ましく、また、細胞群Cgも内筒部30の内部に取り込まれることが好ましい。 Further, when the auxiliary substance is other than a liquid, as described above, the auxiliary substance may be held outside the tip portion of the inner cylinder portion 30 by suction inside the inner cylinder portion 30. However, in order to prevent the auxiliary substances from coming into contact with each other and the auxiliary substances from coming into contact with the cell group Cg in the needle-shaped portion 20 when the cell transplantation device 100 is moved to the transplantation site, the auxiliary substance is other than a liquid. In this case, the auxiliary substance is preferably taken up inside the inner cylinder portion 30, and the cell group Cg is also preferably taken up inside the inner cylinder portion 30.

[変形例]
針状部20の先端部は、2以上の内筒部30を同時に通すことの可能な内径を有し、開口部11は、2以上の内筒部30の先端部を同時に突出させることの可能な大きさを有していてもよい。
[Modification example]
The tip of the needle-shaped portion 20 has an inner diameter that allows two or more inner cylinders 30 to pass through at the same time, and the opening 11 allows the tips of two or more inner cylinders 30 to protrude at the same time. May have a large size.

例えば、図8が示す細胞移植装置110において、針状部20は、一定の内径で延び、針先部10と収容部15とが互いに同一の内径で連続している形状に対応する形状を有している。針状部20は、すべての内筒部30をまとめて収容可能な大きさの内径を有する。 For example, in the cell transplantation device 110 shown in FIG. 8, the needle-shaped portion 20 extends with a constant inner diameter, and has a shape corresponding to a shape in which the needle tip portion 10 and the accommodating portion 15 are continuous with the same inner diameter. doing. The needle-shaped portion 20 has an inner diameter large enough to accommodate all the inner cylinder portions 30 together.

そして、駆動部40は、すべての内筒部30を同時に、針状部20の延びる方向に沿って動かす。すなわち、駆動部40は、すべての内筒部30の先端部が針状部20の内部に位置した状態と、すべての内筒部30の先端部が開口部11から突き出した状態との間で、これらの内筒部30を針状部20に対して相対的に動かす。図9は、すべての内筒部30aの先端部が開口部11から突き出している状態を示す。図9では、針状部20の延びる方向において、すべての内筒部30aの先端の位置が揃っている形態を示しているが、複数の内筒部30は、これらの先端の位置が揃っていない状態で、同時に動かされてもよい。例えば、細胞群Cgを移送するための内筒部30の先端部は、他の内筒部30よりも下方に突出していてもよい。 Then, the drive unit 40 simultaneously moves all the inner cylinder portions 30 along the extending direction of the needle-shaped portion 20. That is, the drive unit 40 is between a state in which the tips of all the inner cylinders 30 are located inside the needle-shaped portion 20 and a state in which the tips of all the inner cylinders 30 protrude from the opening 11. , These inner cylinder portions 30 are moved relative to the needle-shaped portion 20. FIG. 9 shows a state in which the tip portions of all the inner cylinder portions 30a protrude from the opening 11. FIG. 9 shows a form in which the positions of the tips of all the inner cylinders 30a are aligned in the extending direction of the needle-shaped portion 20, but the positions of the tips of the plurality of inner cylinders 30 are aligned. It may be moved at the same time without it. For example, the tip of the inner cylinder portion 30 for transferring the cell group Cg may protrude downward from the other inner cylinder portion 30.

細胞移植装置110を用いて細胞群を移植する際には、細胞群Cgが当該細胞群Cgの移送のための内筒部30に保持された後に、すべての内筒部30の先端部が針状部20内に位置した状態で、針状部20の先端部が移植部位に刺される。そして、すべての内筒部30が同時に動かされ、すべての内筒部30の先端部が開口部11から突き出した状態とされる。内筒部30への補助物質の取り込みは、上記実施形態と同様、針状部20が移植部位に刺される前もしくは後に行われる。そして、細胞群Cgと補助物質とがそれぞれに対応する内筒部30の先端部から放出されることにより、細胞群Cgと補助物質とが生体内に送達される。 When a cell group is transplanted using the cell transplant device 110, after the cell group Cg is held in the inner cylinder portion 30 for transfer of the cell group Cg, the tips of all the inner cylinder portions 30 are needles. The tip of the needle-shaped portion 20 is stabbed into the transplantation site while being located inside the shaped portion 20. Then, all the inner cylinders 30 are moved at the same time, and the tips of all the inner cylinders 30 are in a state of protruding from the opening 11. The uptake of the auxiliary substance into the inner cylinder portion 30 is performed before or after the needle-shaped portion 20 is stabbed at the transplantation site, as in the above embodiment. Then, the cell group Cg and the auxiliary substance are released from the tip of the inner cylinder portion 30 corresponding to each of the cell group Cg and the auxiliary substance, so that the cell group Cg and the auxiliary substance are delivered into the living body.

細胞群Cgの放出と補助物質の放出とは、所定の順番で行われてもよい。あるいは、細胞群Cgの放出と1以上の補助物質の放出とが同時に行われてもよいし、また、複数の補助物質の放出が同時に行われてもよい。 The release of the cell group Cg and the release of the auxiliary substance may be performed in a predetermined order. Alternatively, the release of the cell group Cg and the release of one or more auxiliary substances may be performed at the same time, or the release of a plurality of auxiliary substances may be performed at the same time.

以上のように、複数の内筒部30が同時に動かされる形態であれば、内筒部30を動かすための構成および複数の内筒部30の動きの制御が容易になる。
なお、針状部20の先端部が、複数の内筒部30を同時に通すことの可能な内径を有している場合であっても、上記実施形態と同様に、複数の内筒部30は、内筒部30ごとに動かされ、開口部11からは内筒部30が1つずつ出し入れされてもよい。また、すべての内筒部30のなかの一部である複数の内筒部30が同時に開口部11から出し入れされてもよい。例えば、3つの内筒部30のうちの2つが同時に開口部11から出し入れされてもよい。
As described above, if the plurality of inner cylinders 30 are moved at the same time, the configuration for moving the inner cylinders 30 and the movement of the plurality of inner cylinders 30 can be easily controlled.
Even when the tip of the needle-shaped portion 20 has an inner diameter that allows the plurality of inner cylinder portions 30 to pass through at the same time, the plurality of inner cylinder portions 30 may have the same inner diameter as in the above embodiment. , The inner cylinder portion 30 may be moved for each inner cylinder portion 30, and the inner cylinder portion 30 may be taken in and out one by one from the opening 11. Further, a plurality of inner cylinders 30 which are a part of all the inner cylinders 30 may be taken in and out from the opening 11 at the same time. For example, two of the three inner cylinders 30 may be taken in and out of the opening 11 at the same time.

また、複数の内筒部30を同時に動かすことと、複数の内筒部30を1つずつ動かすこととのいずれもが可能であってもよい。この場合、例えば、細胞群Cgおよび補助物質の取り込みと、細胞群Cgおよび補助物質の放出との一方では、複数の内筒部30が同時に動かされ、他方では、複数の内筒部30が1つずつ動かされてもよい。 Further, it may be possible to move the plurality of inner cylinder portions 30 at the same time and to move the plurality of inner cylinder portions 30 one by one. In this case, for example, in one of the uptake of the cell group Cg and the auxiliary substance and the release of the cell group Cg and the auxiliary substance, the plurality of inner cylinders 30 are simultaneously moved, and in the other, the plurality of inner cylinders 30 are 1. It may be moved one by one.

また、図10が示す細胞移植装置120のように、複数の針状部20が備えられていてもよい。細胞移植装置120は、複数の針状部20と、針状部20ごとに複数の内筒部30とを備えている。各針状部20において、複数の内筒部30には、細胞群を移送するための内筒部30と、補助物質を移送するための内筒部30とが含まれる。図10では、針状部20の先端部の開口部11が、複数の内筒部30を1つずつ通す大きさを有する形態を示しているが、先の図8を用いて説明したように、開口部11は、複数の内筒部30を同時に通す大きさを有していてもよい。各針状部20において、複数の内筒部30は、上述した形態と同様に、1つずつ、あるいは、同時に動かされ、針状部20の先端部の開口部11から出し入れされる。 Further, as in the cell transplantation device 120 shown in FIG. 10, a plurality of needle-shaped portions 20 may be provided. The cell transplantation device 120 includes a plurality of needle-shaped portions 20, and a plurality of inner cylinder portions 30 for each needle-shaped portion 20. In each needle-shaped portion 20, the plurality of inner cylinder portions 30 include an inner cylinder portion 30 for transferring a cell group and an inner cylinder portion 30 for transferring an auxiliary substance. FIG. 10 shows a form in which the opening 11 at the tip of the needle-shaped portion 20 has a size for passing a plurality of inner cylinder portions 30 one by one, but as described with reference to FIG. 8 above. The opening 11 may have a size that allows a plurality of inner cylinders 30 to pass through at the same time. In each needle-shaped portion 20, the plurality of inner cylinder portions 30 are moved one by one or at the same time in the same manner as described above, and are taken in and out from the opening 11 at the tip of the needle-shaped portion 20.

複数の針状部20の配列は特に限定されず、複数の針状部20は規則的に並んでいてもよいし、不規則に並んでいてもよい。細胞移植装置120が複数の針状部20を備えることにより、複数の細胞群Cgをまとめて細胞移植装置120に収容することや、複数の細胞群Cgをまとめて移植の対象領域に配置することが可能である。したがって、細胞群Cgの移植の効率が高められる。 The arrangement of the plurality of needle-shaped portions 20 is not particularly limited, and the plurality of needle-shaped portions 20 may be arranged regularly or irregularly. When the cell transplantation device 120 includes a plurality of needle-shaped portions 20, a plurality of cell group Cg can be collectively accommodated in the cell transplantation device 120, or a plurality of cell group Cg can be collectively arranged in a target region for transplantation. Is possible. Therefore, the efficiency of transplantation of the cell group Cg is enhanced.

以上、上記実施形態および変形例によれば、以下に列挙する効果が得られる。
(1)細胞移植装置100が、細胞群Cgを移送するための内筒部30と、補助物質を移送するための内筒部30とを備えているため、1つの針状部20の内部に細胞群Cgと補助物質とを取り込んで、これらを生体内に移送することができる。そして、1つの針状部20から細胞群Cgと補助物質とを放出することができるため、生体内において細胞群Cgが配置された領域の付近に補助物質を供給することができる。したがって、細胞群Cgと補助物質と生体内に容易に送達することができる。
As described above, according to the above-described embodiment and modification, the effects listed below can be obtained.
(1) Since the cell transplantation device 100 includes an inner cylinder portion 30 for transferring the cell group Cg and an inner cylinder portion 30 for transferring an auxiliary substance, the inside of one needle-shaped portion 20 The cell group Cg and auxiliary substances can be taken up and transferred into the living body. Then, since the cell group Cg and the auxiliary substance can be released from one needle-shaped portion 20, the auxiliary substance can be supplied to the vicinity of the region where the cell group Cg is arranged in the living body. Therefore, the cell group Cg, the auxiliary substance, and the in vivo can be easily delivered.

(2)内筒部30が、内筒部30の先端部が針状部20の内部に位置した第1状態と、内筒部30の先端部が針状部20の先端部の開口部11から突き出した第2状態との間で、針状部20に対して相対的に移動可能である。したがって、第1状態で生体に針状部20を刺すこと、および、第2状態で細胞群Cgおよび補助物質の取り込みや放出を行うことができる。そのため、細胞群Cgおよび補助物質の生体内への送達が円滑に進められる。 (2) The inner cylinder portion 30 is in the first state in which the tip portion of the inner cylinder portion 30 is located inside the needle-shaped portion 20, and the tip portion of the inner cylinder portion 30 is the opening 11 of the tip portion of the needle-shaped portion 20. It is movable relative to the needle-shaped portion 20 with respect to the second state protruding from. Therefore, the needle-shaped portion 20 can be pierced into the living body in the first state, and the cell group Cg and the auxiliary substance can be taken in and released in the second state. Therefore, the delivery of the cell group Cg and the auxiliary substance into the living body is smoothly promoted.

(3)複数の内筒部30が、内筒部30ごとに上記第1状態と上記第2状態との間で移動される形態であれば、複数の内筒部30を1つずつ針状部20の開口部11から出し入れすることができるため、内筒部30の周囲の空間に余裕のある状態で、細胞群Cgおよび補助物質の取り込みや放出を行うことができる。したがって、これらの作業が円滑に進められる。 (3) If the plurality of inner cylinder portions 30 are moved between the first state and the second state for each inner cylinder portion 30, the plurality of inner cylinder portions 30 are needle-shaped one by one. Since it can be taken in and out from the opening 11 of the portion 20, the cell group Cg and the auxiliary substance can be taken in and released in a state where there is a margin in the space around the inner cylinder portion 30. Therefore, these operations can proceed smoothly.

(4)2以上の内筒部30が、同時に、上記第1状態と上記第2状態との間で移動される形態であれば、複数の内筒部30を1つずつ動かす場合と比較して、内筒部30の動きの制御が簡易になる。 (4) If two or more inner cylinder portions 30 are simultaneously moved between the first state and the second state, the case where a plurality of inner cylinder portions 30 are moved one by one is compared with the case where the plurality of inner cylinder portions 30 are moved one by one. Therefore, the movement of the inner cylinder portion 30 can be easily controlled.

(5)細胞群Cgを移送するための内筒部30が、内筒部30内を吸引する機構に接続され、当該吸引によって内筒部30の先端部から内筒部30内に細胞群Cgを取り込む。これによれば、細胞群Cgが細胞の集合体である場合に、細胞群Cgを的確に内筒部30の内部に取り込むことが可能であり、所望の数だけ細胞群Cgを内筒部30内に取り込むことも容易である。 (5) The inner cylinder portion 30 for transferring the cell group Cg is connected to a mechanism for sucking the inside of the inner cylinder portion 30, and the cell group Cg is transferred from the tip end portion of the inner cylinder portion 30 into the inner cylinder portion 30 by the suction. To capture. According to this, when the cell group Cg is an aggregate of cells, the cell group Cg can be accurately taken into the inner cylinder portion 30, and a desired number of cell group Cg can be taken into the inner cylinder portion 30. It is also easy to take in.

(6)補助物質を移送するための内筒部30が、内筒部30の先端部とは反対側から、液体である補助物質を内筒部30内に取り込む。これによれば、液体の特性を生かして効率的に内筒部30への補助物質の取り込みが可能である。また、細胞群Cgと補助物質とで、内筒部30の先端側と基端側とのいずれから移送対象を取り入れるかを変えることで、移送対象の特性に応じた的確な取り込みが可能である。 (6) The inner cylinder portion 30 for transferring the auxiliary substance takes in the auxiliary substance which is a liquid into the inner cylinder portion 30 from the side opposite to the tip portion of the inner cylinder portion 30. According to this, it is possible to efficiently take in the auxiliary substance into the inner cylinder portion 30 by taking advantage of the characteristics of the liquid. In addition, by changing whether the transfer target is taken in from the distal end side or the proximal end side of the inner cylinder portion 30 between the cell group Cg and the auxiliary substance, accurate uptake can be performed according to the characteristics of the transfer target. ..

(7)細胞移植装置120が、複数の針状部20を備え、針状部20ごとに、細胞群Cgを移送するための内筒部30と、補助物質を移送するための内筒部30とを含む複数の内筒部30を備えている。これによれば、複数の細胞群Cgや補助物質をまとめて細胞移植装置120に取り込むことや、複数の細胞群Cgや補助物質をまとめて生体内に配置することが可能であるため、移植の効率が高められる。 (7) The cell transplantation device 120 includes a plurality of needle-shaped portions 20, and for each needle-shaped portion 20, an inner cylinder portion 30 for transferring the cell group Cg and an inner cylinder portion 30 for transferring an auxiliary substance are provided. It is provided with a plurality of inner cylinder portions 30 including and. According to this, a plurality of cell group Cg and auxiliary substances can be collectively taken into the cell transplantation device 120, and a plurality of cell group Cg and auxiliary substances can be collectively arranged in a living body, so that the transplantation can be performed. Efficiency is increased.

[他の変形例]
上記実施形態および変形例は、以下のように変更して実施することが可能である。
・細胞群Cgおよび補助物質の取り込みと、細胞群Cgおよび補助物質の放出との少なくとも一方において、複数の内筒部30は、複数の内筒部30の先端部が針状部20の内部に位置する状態から動かされなくてもよい。例えば、先の図8に示したように、開口部11が複数の内筒部30を同時に通す大きさを有する形態において、複数の内筒部30の先端部が針状部20の内部にて開口部11の付近に位置する状態で、細胞群Cgおよび補助物質の取り込みや放出が行われてもよい。細胞群Cgおよび補助物質の取り込みと放出との双方で複数の内筒部30が動かされない場合には、細胞移植装置は駆動部40を備えていなくてよい。
[Other variants]
The above-described embodiment and modification can be modified and implemented as follows.
-In at least one of the uptake of the cell group Cg and the auxiliary substance and the release of the cell group Cg and the auxiliary substance, the plurality of inner cylinder portions 30 have the tips of the plurality of inner cylinder portions 30 inside the needle-shaped portion 20. It does not have to be moved from its position. For example, as shown in FIG. 8 above, in a form in which the opening 11 has a size for passing a plurality of inner cylinders 30 at the same time, the tips of the plurality of inner cylinders 30 are inside the needle-shaped portion 20. The uptake and release of the cell group Cg and the auxiliary substance may be carried out in a state of being located near the opening 11. If the plurality of inner cylinders 30 are not moved by both the uptake and release of the cell group Cg and the auxiliary substance, the cell transplantation device may not include the drive unit 40.

・内筒部30は、細胞群Cgを移送するための第1内筒部と、補助物質を移送するための第2内筒部とのいずれとしても使用可能であって、第1内筒部として用いるか第2内筒部として用いるかが使用時に決定されてもよい。 -The inner cylinder portion 30 can be used as both a first inner cylinder portion for transferring the cell group Cg and a second inner cylinder portion for transferring an auxiliary substance, and the first inner cylinder portion can be used. It may be decided at the time of use whether it is used as a second inner cylinder portion or as a second inner cylinder portion.

・針状部20の内側への内筒部30の着脱が可能であって、供給が望まれる補助物質の種類や数に応じて、細胞移植装置に取り付けられる内筒部30の増減や交換が行われてもよい。 -The inner cylinder portion 30 can be attached to and detached from the inside of the needle-shaped portion 20, and the inner cylinder portion 30 attached to the cell transplantation device can be increased / decreased or replaced according to the type and number of auxiliary substances desired to be supplied. It may be done.

・第2内筒部の移送対象とされる物質は、細胞群の機能の発現を補助する物質や、針状部20の生体内への進入や引抜を補助する物質に限らず、細胞群と共に生体内に供給されることで所定の機能を発揮する物質であればよい。 -The substances to be transferred in the second inner cylinder are not limited to substances that assist the expression of the function of the cell group and substances that assist the entry and withdrawal of the needle-shaped portion 20 into the living body, and together with the cell group. Any substance that exerts a predetermined function when supplied into a living body may be used.

・移植対象の細胞群は、発毛または育毛に寄与する細胞群でなくてもよく、生体内に配置されることによって、所望の効果を発揮する細胞群であればよい。例えば、移植対象の細胞群は、皮膚における皺の解消や保湿状態の改善等、美容用途での効果を発揮する細胞群であってもよい。 -The cell group to be transplanted does not have to be a cell group that contributes to hair growth or hair growth, and may be a cell group that exerts a desired effect by being arranged in a living body. For example, the cell group to be transplanted may be a cell group that exerts an effect for cosmetic purposes such as elimination of wrinkles on the skin and improvement of a moisturizing state.

[実施例]
上述した細胞移植装置について、具体的な実施例を用いて説明する。
実施例として、図8に対応する細胞移植装置を製作した。実施例の細胞移植装置は、1つの第1内筒部と、1つの第2内筒部との2つの内筒部を備えている。針状部としては、17Gの注射針を用いた。針状部の内径は1.10mmであり、針状部の外径は1.46mmである。第1内筒部および第2内筒部としては、内径が0.17mm、外径が0.36mmの精密パイプを用いた。針状部の内側に2つの内筒部を配置し、各内筒部の基端部にチューブを介してシリンジを接続した。
[Example]
The above-mentioned cell transplantation device will be described with reference to specific examples.
As an example, a cell transplantation device corresponding to FIG. 8 was manufactured. The cell transplantation apparatus of the embodiment includes two inner cylinder portions, one first inner cylinder portion and one second inner cylinder portion. As the needle-shaped part, a 17G injection needle was used. The inner diameter of the needle-shaped portion is 1.10 mm, and the outer diameter of the needle-shaped portion is 1.46 mm. As the first inner cylinder portion and the second inner cylinder portion, precision pipes having an inner diameter of 0.17 mm and an outer diameter of 0.36 mm were used. Two inner cylinders were arranged inside the needle-shaped portion, and a syringe was connected to the base end of each inner cylinder via a tube.

細胞群のモデルとして、平均粒子径が210μmのプラスチックビーズを用意し、補助物質のモデルとして純水を用意した。シリンジを用いて内筒部内を吸引することにより、第1内筒部内にその先端部から1つのプラスチックビーズを取り込み、第2内筒部内にその先端部から純水を取り込んだ。 As a model of the cell group, plastic beads having an average particle size of 210 μm were prepared, and pure water was prepared as a model of an auxiliary substance. By sucking the inside of the inner cylinder portion using a syringe, one plastic bead was taken into the first inner cylinder portion from the tip portion thereof, and pure water was taken into the second inner cylinder portion from the tip portion thereof.

細胞移植装置に取り込んだプラスチックビーズと純水とを、生体の代替であるシリコーン製の試験体に投与する試験を5回行った。各試験の後に、試験体の内部にプラスチックビーズと純水とが配置されているかを確認したところ、5回の試験のすべてにおいて、プラスチックビーズと純水とが針状部の内部に残留することなく、試験体の内部に配置されていることが確認された。したがって、実施例の細胞移植装置を用いて、対象への細胞群と補助物質との送達が可能であることが確認された。 The test of administering the plastic beads and pure water taken into the cell transplantation device to a silicone test piece, which is a substitute for a living body, was carried out five times. After each test, it was confirmed whether the plastic beads and pure water were arranged inside the test piece. In all five tests, the plastic beads and pure water remained inside the needle-shaped part. It was confirmed that it was placed inside the test piece. Therefore, it was confirmed that the cell group and the auxiliary substance can be delivered to the subject using the cell transplantation device of the example.

Cg…細胞群、Pl…保護液、Sl…補助物質、10…針先部、11…開口部、15…収容部、20…針状部、30…内筒部、40…駆動部、41…移送制御部、100,110,120…細胞移植装置。 Cg ... Cell group, Pl ... Protective solution, Sl ... Auxiliary substance, 10 ... Needle tip, 11 ... Opening, 15 ... Containment part, 20 ... Needle-shaped part, 30 ... Inner cylinder part, 40 ... Drive part, 41 ... Transfer control unit, 100, 110, 120 ... Cell transplantation device.

Claims (7)

生体内の対象領域に、細胞群を配置するための細胞移植装置であって、
1つの方向に沿って延びる筒状の針状部と、
前記針状部の内側に位置する複数の内筒部と、を備え、
前記複数の内筒部には、前記細胞群を移送するための第1内筒部と、前記細胞群以外の物質を移送するための第2内筒部とが含まれる
細胞移植装置。
A cell transplantation device for arranging a group of cells in a target area in a living body.
A tubular needle that extends in one direction,
A plurality of inner cylinder portions located inside the needle-shaped portion are provided.
A cell transplantation apparatus including a first inner cylinder portion for transferring the cell group and a second inner cylinder portion for transferring a substance other than the cell group in the plurality of inner cylinder portions.
前記内筒部は、前記内筒部の先端部が前記針状部の内部に位置した第1状態と、前記内筒部の先端部が前記針状部の先端部の開口部から突き出した第2状態との間で、前記針状部に対して相対的に移動可能に構成されている
請求項1に記載の細胞移植装置。
The inner cylinder portion has a first state in which the tip portion of the inner cylinder portion is located inside the needle-shaped portion and a first state in which the tip portion of the inner cylinder portion protrudes from the opening of the tip portion of the needle-shaped portion. The cell transplantation apparatus according to claim 1, which is configured to be movable relative to the needle-shaped portion between the two states.
前記複数の内筒部は、前記内筒部ごとに、前記第1状態と前記第2状態との間で移動可能に構成されている
請求項2に記載の細胞移植装置。
The cell transplantation apparatus according to claim 2, wherein the plurality of inner cylinder portions are configured to be movable between the first state and the second state for each inner cylinder portion.
2以上の前記内筒部が、同時に、前記第1状態と前記第2状態との間で移動可能に構成されている
請求項2に記載の細胞移植装置。
The cell transplantation apparatus according to claim 2, wherein two or more inner cylinder portions are configured to be movable between the first state and the second state at the same time.
前記細胞群は、細胞の集合体であり、
前記第1内筒部は、前記第1内筒部内を吸引する機構に接続され、前記吸引によって前記第1内筒部の先端部から前記第1内筒部内に前記細胞群を取り込む
請求項1〜4のいずれか一項に記載の細胞移植装置。
The cell group is an aggregate of cells.
The first inner cylinder portion is connected to a mechanism for sucking the inside of the first inner cylinder portion, and the cell group is taken into the first inner cylinder portion from the tip end portion of the first inner cylinder portion by the suction. 4. The cell transplantation apparatus according to any one of 4.
前記複数の内筒部が含む少なくとも1つの前記第2内筒部は、前記細胞群以外の物質である液体を移送するための前記第2内筒部であって、前記第2内筒部の先端部とは反対側から、前記第2内筒部内に前記物質を取り込む
請求項1〜5のいずれか一項に記載の細胞移植装置。
The at least one second inner cylinder portion included in the plurality of inner cylinder portions is the second inner cylinder portion for transferring a liquid which is a substance other than the cell group, and is the second inner cylinder portion of the second inner cylinder portion. The cell transplantation apparatus according to any one of claims 1 to 5, wherein the substance is taken into the second inner cylinder portion from the side opposite to the tip portion.
複数の前記針状部を備え、
前記針状部ごとに、前記第1内筒部と前記第2内筒部とを含む複数の前記内筒部を備える
請求項1〜6のいずれか一項に記載の細胞移植装置。
With a plurality of the needle-shaped portions,
The cell transplantation apparatus according to any one of claims 1 to 6, wherein each needle-shaped portion includes a plurality of the inner cylinder portions including the first inner cylinder portion and the second inner cylinder portion.
JP2020026242A 2020-02-19 2020-02-19 Cell Transplantation Device Active JP7484211B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020026242A JP7484211B2 (en) 2020-02-19 2020-02-19 Cell Transplantation Device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020026242A JP7484211B2 (en) 2020-02-19 2020-02-19 Cell Transplantation Device

Publications (2)

Publication Number Publication Date
JP2021129702A true JP2021129702A (en) 2021-09-09
JP7484211B2 JP7484211B2 (en) 2024-05-16

Family

ID=77551473

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020026242A Active JP7484211B2 (en) 2020-02-19 2020-02-19 Cell Transplantation Device

Country Status (1)

Country Link
JP (1) JP7484211B2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040106896A1 (en) 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US9149602B2 (en) 2005-04-22 2015-10-06 Advanced Cardiovascular Systems, Inc. Dual needle delivery system
JP6828763B2 (en) 2019-03-29 2021-02-10 凸版印刷株式会社 Biological transfer device

Also Published As

Publication number Publication date
JP7484211B2 (en) 2024-05-16

Similar Documents

Publication Publication Date Title
US7922688B2 (en) Automated delivery of a therapeutic or cosmetic substance to cutaneous, subcutaneous and intramuscular tissue regions
CN108042887B (en) Injection device
JP7184005B2 (en) Cell transplantation device
JP2021129702A (en) Cell transplantation device
JP6828763B2 (en) Biological transfer device
JP2021074571A (en) Transfer device for living body and method of using transfer device for living body
CN209074788U (en) Fatty surgical needles
WO2022244855A1 (en) Device for cosmetic therapy
WO2021162068A1 (en) Transfer device for living body
JP7230643B2 (en) Living body transfer device, member for living body transfer device, living body transfer unit, and living body transfer kit
JP2010540425A (en) Epidermal stimulation to enhance hair follicle formation
JP2023177484A (en) Organism transfer device
JP6828764B2 (en) Cell transplant device
JP7481693B2 (en) Cell Transplantation Device
JP7230644B2 (en) Cell transplantation device
JP2022096765A (en) Cell transplantation apparatus, and method for using cell transplantation apparatus
WO2022050408A1 (en) Cell transplanting kit, cell transplanting device, and method for taking in transplant
JP2023111296A (en) Cell transplantation device
JP6791291B2 (en) Cell transplant device
JP2021112334A (en) Cell transplantation device
JP2023105699A (en) Carrier device
JP2023172214A (en) Cell transplantation device
JP2022178516A (en) Device for cosmetic therapy

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230125

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20231218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231226

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240226

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240402

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240415

R150 Certificate of patent or registration of utility model

Ref document number: 7484211

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150